Outcome analysis according to treatment aim and patient selection (see also figure 1), n/N (%)
| Free of neoplasia | Free of neoplasia and Barrett epithelium | |
|---|---|---|
| ITT including all cases | 76/179 (40.25) | 44/179 (24.6) |
| ITT excluding surgical cases but including cases without adequate follow-up* (n=42) counted free of neoplasia | 76/138 (55.1) | N/A |
| ITT excluding surgical cases and cases in whom complete ablation was not intended, but including all cases without adequate follow-up* (n=42) counted free of neoplasia | 76/132 (57.6) | N/A |
| ITT excluding surgical cases and cases in whom complete ablation was not intended, but including cases with some follow-up* (n=29) counted free of neoplasia | 76/119 (63.9) | N/A |
| ITT excluding surgical cases and cases in whom complete ablation was not intended, excluding cases without adequate follow-up (n=42) | 76/90 (80.4) | 44/90 (48.9) |
| Cases with complete eradication, adequate follow-up (2 negative endoscopies/biopsies) | 76/81 (93.8) | 44/81 (54.3) |
*Including at least two endoscopies with biopsies and a minimum of 3 years.
ITT, intention to treat; N/A, not assessable because endoscopic biopsy not done and/or results not available.